Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction

oleh: Oriol Iborra-Egea, Oriol Iborra-Egea, Alberto Aimo, Alberto Aimo, Antoni Bayes-Genis, Antoni Bayes-Genis, Antoni Bayes-Genis

Format: Article
Diterbitkan: Frontiers Media S.A. 2022-05-01

Deskripsi

Subjek

heart failure; CDR132L; therapy; myocardial infarction; models